Literature DB >> 9529013

Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma.

E Otsuji1, T Yamaguchi, K Sawai, A Hagiwara, H Taniguchi, T Takahashi.   

Abstract

BACKGROUND: Mortality resulting from gastric carcinoma is decreasing. This is mainly due to vigorous endoscopic screening and the consequent higher incidence of early detection of the disease. In this study, to evaluate the effect of surgical treatment on the prognoses of patients with gastric carcinoma, the survival of 1579 patients who underwent gastrectomy between 1970 and 1994 was retrospectively analyzed.
METHODS: The patients were divided into 5 groups at 5-year intervals. Postoperative survival was compared among the groups.
RESULTS: Postoperative survival was significantly improved in the later groups for patients with Stage I, II, III, and IV disease. A multivariate analysis of prognostic factors revealed that the time period during which the gastrectomy was performed was an independent predictor of survival.
CONCLUSIONS: It was concluded that survival has been improved by recent advances in the surgical approach to gastric carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9529013

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Authors:  F Bozzetti; E Marubini; G Bonfanti; R Miceli; C Piano; L Gennari
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice.

Authors:  Ai-Guang Zhao; Hai-Lei Zhao; Xiao-Jie Jin; Jin-Kun Yang; Lai-Di Tang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Use of laparoscopy as an alternative to computed tomography (CT) and positron emission tomography (PET) scans for the detection of recurrence in patients with gastric cancer: a pilot study.

Authors:  Jung Ho Shim; Han Mo Yoo; Han Hong Lee; Jun Gi Kim; Hae Myung Jeon; Kyo Young Song; Cho Hyun Park
Journal:  Surg Endosc       Date:  2011-05-02       Impact factor: 4.584

4.  Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.

Authors:  San-Chi Chen; Chia-Jen Liu; Yu-Wen Hu; Chiu-Mei Yeh; Li-Yu Hu; Yen-Po Wang; Yi-Ping Hung; Cheng-Hwai Tzeng; Tzeon-Jye Chiou; Tzeng-Ji Chen; Chung-Jen Teng
Journal:  Gastric Cancer       Date:  2015-03-13       Impact factor: 7.370

5.  Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.

Authors:  Jung Ho Shim; Joo Hyun O; Seong Il Oh; Han Mo Yoo; Hae Myung Jeon; Cho Hyun Park; Sung Hoon Kim; Kyo Young Song
Journal:  J Gastrointest Surg       Date:  2012-06-30       Impact factor: 3.452

6.  Expression of human epidermal growth factor receptor 2 in primary and paired parenchymal recurrent and/or metastatic sites of gastric cancer.

Authors:  Ryosuke Shibata; Satoshi Nimura; Tatsuya Hashimoto; Toru Miyake; Shinsuke Takeno; Seiichiro Hoshino; Kazuki Nabeshima; Yuichi Yamashita
Journal:  Mol Clin Oncol       Date:  2014-06-27

7.  Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection.

Authors:  Jung-Wook Kim; Jae-Young Jang; Young Woon Chang; Yong Ho Kim
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

8.  Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.

Authors:  Joo Hoon Kim; Sun Young Rha; Chan Kim; Gun Min Kim; Sang Hyun Yoon; Ki Hyang Kim; Min Jae Kim; Joong Bae Ahn; Hyun Cheol Chung; Jae Kyung Roh; Hyo Song Kim
Journal:  Cancer Res Treat       Date:  2010-12-31       Impact factor: 4.679

9.  Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions.

Authors:  Y Tajima; K Yamazaki; N Nishino; K Morohara; T Yamazaki; T Kaetsu; S Suzuki; M Kawamura; K Kumagai; M Kusano
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

10.  Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.

Authors:  Chan Kim; Hong Chon; Beodeul Kang; Kiyeol Kim; Hei-Cheul Jeung; Hyun Chung; Sung Noh; Sun Rha
Journal:  BMC Cancer       Date:  2013-08-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.